| Literature DB >> 32456528 |
T J Lacker1,2, A Walther1,2,3, U Ehlert1,2.
Abstract
While life expectancy continues to increase, aging can bringEntities:
Keywords: aging; endocrine changes; healthy aging; longitudinal; male; men’s health; self-esteem; social support
Mesh:
Substances:
Year: 2020 PMID: 32456528 PMCID: PMC7278106 DOI: 10.1177/1557988320926332
Source DB: PubMed Journal: Am J Mens Health ISSN: 1557-9883
Figure 1.Flow Chart of Participant Participation
Sample Characteristics.
| Baseline | Follow-up | |||||
|---|---|---|---|---|---|---|
|
| M/Freq. |
| M/Freq. | |||
| Age | 97 | 61.26 | 10.02 | 97 | 65.18 | 9.98 |
| Fat mass in percent (%) | 95 | 22.42 | 5.43 | 97 | 20.58 | 7.03 |
| C (nmol/L) | 95 | 4.77 | 8.99 | 97 | 6.76 | 9.28 |
| T (pg/ml) | 93 | 42.53 | 18.44 | 96 | 37.88 | 26.28 |
| DHEAs (ng/ml) | 95 | 1.95 | 1.31 | 97 | 1.31 | 1.06 |
| E2 (pg/ml) | 94 | 1.46 | 1.06 | 97 | 1.63 | 1.69 |
| P (pg/ml) | 94 | 34.29 | 13.04 | 97 | 45.03 | 36.08 |
| AMS—main score | 89 | 26.22 | 6.93 | 94 | 26.74 | 6.68 |
| SF-36—physical health | 97 | 65.47 | 3.93 | 96 | 65.36 | 4.09 |
| BSI—main score | 97 | 22.43 | 5.28 | 94 | 21.90 | 3.74 |
| IIEF—sexual function | 96 | 28.61 | 6.98 | 94 | 28.10 | 6.73 |
| MSWS—main score | 96 | 179.80 | 20.68 | 94 | 180.21 | 19.89 |
| BSSS—main score | 96 | 3.44 | 0.51 | 94 | 3.52 | 0.43 |
| Marital status (%) | 97 | 96 | ||||
| Single | 8 | 8.25 | 5 | 5.21 | ||
| In relationship | 8 | 8.25 | 10 | 10.42 | ||
| Married | 70 | 72.16 | 70 | 72.92 | ||
| Divorced | 10 | 10.31 | 10 | 10.42 | ||
| Widowed | 1 | 1.03 | 1 | 1.04 | ||
| Education (%) | 97 | 96 | ||||
| Lower-track secondary school | 8 | 8.25 | 9 | 9.38 | ||
| Medium-track secondary school | 23 | 23.7 | 23 | 23.96 | ||
| Higher-tracker secondary school | 7 | 7.22 | 7 | 7.29 | ||
| University degree | 43 | 44.33 | 46 | 47.92 | ||
| Other | 16 | 16.49 | 11 | 11.46 | ||
| Income (in CHF, %) | 97 | 96 | ||||
| No income | 1 | 1.03 | 1 | 1.04 | ||
| Up to 30,000 | 3 | 3.09 | 3 | 3.13 | ||
| 30,001–50,000 | 7 | 7.22 | 4 | 4.17 | ||
| 50,001–100,000 | 35 | 36.08 | 38 | 39.58 | ||
| 100,001–150,000 | 35 | 36.08 | 38 | 39.58 | ||
| 150,001–200,000 | 12 | 12.37 | 7 | 7.29 | ||
| More than 200,000 | 4 | 4.12 | 5 | 5.21 | ||
| Number of children (%) | 97 | 96 | ||||
| 0 | 20 | 20.62 | 19 | 19.79 | ||
| 1 | 14 | 14.43 | 15 | 15.63 | ||
| 2 | 42 | 43.30 | 40 | 41.67 | ||
| 3 | 18 | 18.56 | 18 | 18.75 | ||
| 4 | 2 | 2.06 | 3 | 3.13 | ||
| 5 or more | 1 | 1.03 | 1 | 1.04 | ||
| Smoking (%) | 97 | 96 | ||||
| Nonsmoking | 82 | 84.54 | 83 | 86.46 | ||
| Smoking | 15 | 15.46 | 13 | 13.54 | ||
| Medication (%) | 97 | 96 | ||||
| No | 59 | 60.08 | 51 | 53.13 | ||
| Yes | 38 | 39.18 | 45 | 46.88 | ||
| Type of medication[ | 38 | 45 | ||||
| Antihypertensives | 23 | 45.09 | 28 | 45.16 | ||
| Vitamins and minerals | 1 | 1.96 | 5 | 8.06 | ||
| Other | 27 | 52.94 | 29 | 46.77 | ||
| Physical activity (%) | 97 | 96 | ||||
| Less than 1 hr | 1 | 1.03 | 1 | 1.04 | ||
| 1–3 hr | 32 | 32.99 | 20 | 20.83 | ||
| 4–6 hr | 40 | 41.24 | 51 | 53.13 | ||
| 7 hr or more | 24 | 24.74 | 24 | 25.00 | ||
Participants could indicate more than one medication.
Note. N = number of participants; M = mean; Freq. = frequency; SD = standard deviation; % = percent; C = cortisol; T = testosterone; DHEAs = dehydroepiandrosterone-sulfate; E2 = estradiol; P = progesterone; AMS = Aging Males’ Symptoms scale; SF-36 = Short-Form 36; BSI = brief symptom inventory; IIEF = International Index of Erectile Function; MSWS = Multidimensional Self-Esteem Scale; BSSS = Berlin Social Support Scale; CHF = Swiss Francs.
Figure 2.Changes Over Time for Endocrine Markers and Psychosocial Measures. (A) Shows the changes over time for endocrine measures. DHEAs = dehydroepiandrosterone-sulfate; E2 = estradiol. Changes on percent scale with higher values are shown as 100%. (B) Shows the change over time of psychosocial measures. Scale shows percent of maximum achievable value on respective questionnaire scale. For mean and SD see Table 2.
Linear Mixed Model Results Over Time.
| AIC0 | AIC | Estimate | SE |
|
| 95% CIlower | 95% CIupper | |
|---|---|---|---|---|---|---|---|---|
| C | 573.9 | 579.7 | 0.44 | 0.15 | 0.003 | 0.01 | 0.144 | 1.114 |
| T | 375.9 | 370.4 | −0.3 | 0.08 | < .001 | < .001 | −0.457 | −0.147 |
| DHEAs | 409.6 | 358.7 | −0.47 | 0.05 | < .001 | < .001 | −0.587 | −0.36 |
| E2 | 433.6 | 447.5 | 0.07 | 0.09 | 0.413 | 0.623 | −1.102 | 0.247 |
| P | 189.1 | 187.6 | 0.2 | 0.05 | < .001 | 0.001 | 0.1 | 0.302 |
| AMS | −59 | −51.9 | 0.03 | 0.02 | 0.104 | 0.19 | −0.006 | 0.067 |
| SF-36 | 1042 | 1050.3 | −0.32 | 0.38 | 0.403 | 0.506 | −1.081 | 0.431 |
| BSI | 1116.3 | 1122.4 | −0.04 | 0.55 | 0.47 | 0.623 | −1.5 | 0.7 |
| IIEF | 1254 | 1258.4 | −0.91 | 0.76 | 0.234 | 0.368 | −2.411 | 0.595 |
| MSWS | 1608.5 | 1621.1 | −0.6 | 1.45 | 0.682 | 0.682 | −2.85 | 3.06 |
| BSSS | 193.4 | 206.1 | 0.09 | 0.04 | 0.019 | 0.042 | 0.015 | 0.16 |
Note. N = 97; AIC0 = Akaike information criterion of the null model; AIC = Akaike information criterion; SE = standard error; p = p value; pcorr = corrected p value; CI = confidence interval; C = cortisol; T = testosterone; DHEAs = dehydroepiandrosterone-sulfate; E2 = estradiol; P = progesterone; AMS = Aging Males’ Symptoms scale; SF-36 = Short-Form 36; BSI = brief symptom inventory; IIEF = International Index of Erectile Function; MSWS = Multidimensional Self-Esteem Scale; BSSS = Berlin Social Support Scale. All calculations controlled for physical activity, educational level, and income; endocrine and health-related measures further controlled for fat mass.
Linear Mixed Model Results for All Moderation Analyses.
| AIC0 | AIC | Estimate | SE |
|
| 95% CIlower | 95% CIupper | |
|---|---|---|---|---|---|---|---|---|
| MSWS*C | 573.9 | 577.1 | 0.002 | 0.007 | 0.736 | 0.897 | −0.012 | 0.017 |
| BSSS*C | 573.9 | 573.9 | 0.544 | 0.316 | 0.087† | 0.696 | −0.078 | 1.165 |
| MSWS*T | 375.9 | 346.5 | −0.003 | 0.004 | 0.346 | 0.865 | −0.011 | 0.004 |
| BSSS*T | 375.9 | 342.2 | 0.214 | 0.164 | 0.195 | 0.865 | −0.114 | 0.537 |
| MSWS*DHEAs | 409.6 | 359.7 | 0.001 | 0.003 | 0.791 | 0.897 | −0.007 | 0.005 |
| BSSS*DHEAs | 409.6 | 359.7 | 0.010 | 0.126 | 0.079† | 0.696 | −0.239 | 0.260 |
| MSWS*E2 | 433.6 | 445.8 | 0.001 | 0.004 | 0.323 | 0.865 | −0.007 | 0.010 |
| BSSS*E2 | 433.6 | 443.8 | −0.112 | 0.191 | 0.559 | 0.897 | −0.489 | 0.267 |
| MSWS*P | 189.1 | 185.0 | −0.001 | 0.003 | 0.665 | 0.897 | −0.006 | 0.004 |
| MSWS*P | 189.1 | 187.6 | 0.013 | 0.111 | 0.908 | 0.908 | −0.230 | 0.198 |
| C*SF36 | 1042 | 1053.3 | 0.051 | 0.051 | 0.319 | 0.865 | −0.049 | 0.152 |
| T*SF36 | 1042 | 1037.0 | −0.020 | 0.021 | 0.333 | 0.865 | −0.062 | 0.021 |
| DHEAs*SF36 | 1042 | 1051.2 | −0.261 | 0.337 | 0.440 | 0.880 | −0.926 | 0.401 |
| E2*SF36 | 1042 | 1049.7 | 0.100 | 0.339 | 0.291 | 0.865 | −0.571 | 0.769 |
| P*SF36 | 1042 | 1045.0 | −0.039 | 0.026 | 0.134 | 0.865 | −0.091 | 0.012 |
| C*AMS | −59 | −48.9 | 0.002 | 0.002 | 0.341 | 0.865 | −0.003 | 0.007 |
| T*AMS | −59 | −45.9 | 0.002 | 0.001 | 0.884 | 0.908 | −0.002 | 0.002 |
| DHEAs*AMS | −59 | −48.4 | −0.011 | 0.016 | 0.525 | 0.897 | −0.043 | 0.022 |
| E2*AMS | −59 | −46.2 | 0.004 | 0.018 | 0.803 | 0.897 | −0.030 | 0.039 |
| P*AMS | −59 | −46.6 | 0.0004 | 0.001 | 0.748 | 0.897 | −0.002 | 0.003 |
| C*BSI | 1116.3 | 1125.8 | −0.036 | 0.069 | 0.602 | 0.897 | −0.172 | 0.010 |
| T*BSI | 1116.3 | 1111.5 | −0.011 | 0.029 | 0.704 | 0.897 | −0.068 | 0.046 |
| DHEAs*BSI | 1116.3 | 1125.0 | −0.519 | 0.489 | 0.291 | 0.865 | −1.485 | 0.448 |
| E2*BSI | 1116.3 | 1119.5 | 0.673 | 0.470 | 0.154 | 0.865 | −0.256 | 1.600 |
| P*BSI | 1116.3 | 1119.4 | −0.019 | 0.035 | 0.580 | 0.897 | −0.089 | 0.511 |
| C*IIEF | 1254 | 1284.8 | 0.198 | 0.102 | 0.055† | 0.696 | −0.007 | 0.399 |
| T*IIEF | 1254 | 1267.4 | 0.030 | 0.042 | 0.481 | 0.897 | −0.054 | 0.114 |
| DHEAs*IIEF | 1254 | 1287.0 | 1.410 | 0.723 | 0.054† | 0.696 | −0.026 | 2.835 |
| E2*IIEF | 1254 | 1284.0 | 0.174 | 0.715 | 0.807 | 0.897 | −1.274 | 1.590 |
| P*IIEF | 1254 | 1282.5 | 0.011 | 0.054 | 0.839 | 0.907 | −0.096 | 0.117 |
| C*MSWS | 1608.5 | 1616.8 | 0.062 | 0.205 | 0.762 | 0.897 | −0.341 | 0.472 |
| T*MSWS | 1608.5 | 1595.3 | −0.072 | 0.084 | 0.400 | 0.872 | −0.241 | 0.094 |
| DHEAs*MSWS | 1608.5 | 1617.8 | −0.551 | 1361 | 0.686 | 0.897 | −3.234 | 2.160 |
| E2*MSWS | 1608.5 | 1610.1 | 0.162 | 1.362 | 0.906 | 0.908 | −2.525 | 2.867 |
| P*MSWS | 1608.5 | 1610.1 | −0.089 | 0.109 | 0.414 | 0.872 | −0.306 | 0.126 |
| C*BSSS | 193.4 | 204.1 | 0.013 | 0.005 | 0.012* | 0.480 | 0.003 | 0.023 |
| T*BSSS | 193.4 | 205.4 | −0.001 | 0.002 | 0.657 | 0.897 | −0.005 | 0.003 |
| DHEAs*BSSS | 193.4 | 208.5 | 0.046 | 0.034 | 0.176 | 0.865 | −0.021 | 0.113 |
| E2*BSSS | 193.4 | 207.7 | 0.028 | 0.034 | 0.412 | 0.872 | −0.039 | 0.095 |
| P*BSSS | 193.4 | 208.2 | −−0.001 | 0.003 | 0.627 | 0.897 | −0.007 | 0.004 |
Note. N = 97; AIC0 = Akaike information criterion of the null model; AIC = Akaike information criterion; SE = standard error; p = p value; pcorr = corrected p value; CI = confidence interval; C = cortisol; T = testosterone; DHEAs = dehydroepiandrosterone-sulfate; E2 = estradiol; P = progesterone; SF36 = Short-Form 36; AMS = Aging Males’ Symptoms scale; BSI = brief symptom inventory; IIEF = International Index of Erectile Function; MSWS = Multidimensional Self-esteem Scale; BSSS = Berlin Social Support Scale. All calculations controlled for physical activity, educational level, and income; endocrine and health-related measures further controlled for fat mass.